Abstract
Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have